Richard Webster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard Webster has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Deepti Reddy
Children's Hospital of Eastern Ontario Research Institute, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada
5 shared publications - Alexandra Ahmet
Division of Endocrinology, Children's Hospital of Eastern Ontario and Department of Pediatrics University of Ottawa Ottawa Ontario Canada
2 shared publications - Caroline Zuijdwijk
Division of Endocrinology, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada, 1 613-737-7600
2 shared publications - Daniela Pohl
Children's Hospital of Eastern Ontario
2 shared publications - Denise Thomson
Department of Pediatrics, Cochrane Planetary Health Thematic Group University of Alberta Edmonton Canada
2 shared publications - Ellen B. Goldbloom
Division of Endocrinology, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada, 1 613-737-7600
2 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89519
Evaluating Patient-Entered Electronic Health Data as a Strategy to Improve Quality of Care in a Diabetes Clinic: Protocol for a Randomized Controlled Trial
Background: Quality care for pediatric type 1 diabetes (T1D) requires frequent, multidisciplinary visits. Technological and clinical innovation have led to changes in T1D management, resulting in increasing data exchange required during these visits. Capturing comprehensive personal health and diabetes-related information discretely and integrating it into the clinical workflow is critical for optimal T1D care but is time-consuming. Time spent on data transfer often results in less time for holistic care and can lead to unmet needs for patients, families, and health care providers, as well as increased time pressures in clinic. To address this, the Children’s Hospital of Eastern Ontario developed a caregiver proxy-reported questionnaire distributed via the MyChart patient portal, allowing families to input care information ahead of visits with the aim of dedicating more clinic time to personalized care. The launch of this tool, which integrates caregiver-entered information into the physician’s documentation workflow, brings the opportunity to systematically evaluate its impact on care quality and efficiency, with potential implications for broader adoption. Objective: Our objective is to evaluate the impact of a caregiver proxy-reported, electronic health record–integrated preclinic questionnaire (MyChart questionnaire) on the quality of care in a pediatric diabetes clinic, through measurement of its impact on caregiver-perceived quality of care compared to the standard of care using 2 validated measures of care quality. We also aim to explore the impact of the intervention on glycemic control and visit efficiency. Methods: We conducted a single-center, parallel-group randomized controlled trial designed for 222 children with T1D. Participants were randomly allocated in a 1:1 ratio to either the intervention (MyChart questionnaire) or standard care. Our primary outcome is caregiver-perceived quality of care, as measured by the Patient’s Evaluation of the Quality of Diabetes Care at 8 months, administered with caregivers serving as proxy respondents for patients. Secondary outcomes are the Patient’s Evaluation of the Quality of Diabetes Care at 4 months and Perceived Quality of Medical Care at 4 and 8 months. Tertiary outcomes include glycemic control and physician-reported visit efficiency at 4 and 8 months. Analysis of covariance models will be used to assess changes between baseline and postintervention outcomes across treatment groups. Results: Recruitment for this study began in April 2023 and was completed in February 2024, with a total of 139 participants enrolled. Data collection has concluded, and the first results are expected in the spring of 2026. Conclusions: This study is the first randomized trial to assess the impact of a caregiver proxy-reported, electronic health record–integrated, preclinic questionnaire distributed via a patient portal on caregiver-perceived quality of care in a pediatric care setting. The results will guide changes in health service infrastructure and delivery to enhance comprehensive data capture and improve care quality within and beyond pediatric T1D.
- 8 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89519
Open AccessEvaluating Patient-Entered Electronic Health Data as a Strategy to Improve Quality of Care in a Diabetes Clinic: Protocol for a Randomized Controlled Trial
Background: Quality care for pediatric type 1 diabetes (T1D) requires frequent, multidisciplinary visits. Technological and clinical innovation have led to changes in T1D management, resulting in increasing data exchange required during these visits. Capturing comprehensive personal health and diabetes-related information discretely and integrating it into the clinical workflow is critical for optimal T1D care but is time-consuming. Time spent on data transfer often results in less time for holistic care and can lead to unmet needs for patients, families, and health care providers, as well as increased time pressures in clinic. To address this, the Children’s Hospital of Eastern Ontario developed a caregiver proxy-reported questionnaire distributed via the MyChart patient portal, allowing families to input care information ahead of visits with the aim of dedicating more clinic time to personalized care. The launch of this tool, which integrates caregiver-entered information into the physician’s documentation workflow, brings the opportunity to systematically evaluate its impact on care quality and efficiency, with potential implications for broader adoption. Objective: Our objective is to evaluate the impact of a caregiver proxy-reported, electronic health record–integrated preclinic questionnaire (MyChart questionnaire) on the quality of care in a pediatric diabetes clinic, through measurement of its impact on caregiver-perceived quality of care compared to the standard of care using 2 validated measures of care quality. We also aim to explore the impact of the intervention on glycemic control and visit efficiency. Methods: We conducted a single-center, parallel-group randomized controlled trial designed for 222 children with T1D. Participants were randomly allocated in a 1:1 ratio to either the intervention (MyChart questionnaire) or standard care. Our primary outcome is caregiver-perceived quality of care, as measured by the Patient’s Evaluation of the Quality of Diabetes Care at 8 months, administered with caregivers serving as proxy respondents for patients. Secondary outcomes are the Patient’s Evaluation of the Quality of Diabetes Care at 4 months and Perceived Quality of Medical Care at 4 and 8 months. Tertiary outcomes include glycemic control and physician-reported visit efficiency at 4 and 8 months. Analysis of covariance models will be used to assess changes between baseline and postintervention outcomes across treatment groups. Results: Recruitment for this study began in April 2023 and was completed in February 2024, with a total of 139 participants enrolled. Data collection has concluded, and the first results are expected in the spring of 2026. Conclusions: This study is the first randomized trial to assess the impact of a caregiver proxy-reported, electronic health record–integrated, preclinic questionnaire distributed via a patient portal on caregiver-perceived quality of care in a pediatric care setting. The results will guide changes in health service infrastructure and delivery to enhance comprehensive data capture and improve care quality within and beyond pediatric T1D.
- Open Access
- 13 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Can We Improve Quality of Care in a Diabetes Clinic Through Patient-Entered Electronic Health Data?: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Quality care for pediatric type 1 diabetes (T1D) requires frequent, multidisciplinary visits. Technological and clinical innovation have led to changes in T1D management resulting in increasing data exchange required during these visits. Capturing comprehensive personal health and diabetes-related information discretely and integrating it into the clinical workflow is critical for optimal T1D care, but time consuming. Time spent on data transfer often results in less time for holistic care, and can result in unmet needs for patients, families and health care providers, and increased time pressures in clinic. To address this, the Children’s Hospital of Eastern Ontario (CHEO) developed a caregiver proxy-reported questionnaire distributed via the MyChart® patient portal, allowing families to input care information ahead of visits, with the aim of dedicating more clinic time to personalized care. The launch of this tool that integrates caregiver-entered information directly into the physician’s documentation workflow, brings the opportunity to systematically evaluate its impact on care quality and efficiency, with potential implications for broader adoption. OBJECTIVE Our objective is to evaluate the impact of a caregiver proxy-reported, EHR-integrated pre-clinic questionnaire (MyChart questionnaire) on the quality of care in a pediatrics diabetes clinic, through measurement of its impact on caregiver-perceived quality of care compared to standard of care using two validated measures of care quality. We also aim to explore the impact of the intervention on glycemic control and visit efficiency. METHODS We conducted a single-centre, parallel-group randomized controlled trial designed for 222 children with T1D. Participants were randomly allocated in a 1:1 ratio to either the intervention (MyChart questionnaire) or standard care. Our primary outcome is caregiver-perceived quality of care as measured by the Patient’s Evaluation of the Quality of Diabetes Care (PEQD) at 8 months, administered with caregivers serving as proxy respondents for patients. Secondary outcomes are the PEQD at 4 months and Perceived Quality of Medical Care (PQMC) at 4 and 8 months. Tertiary outcomes include glycemic control and physician-reported visit efficiency at 4 and 8 months. ANCOVA models will be used to assess changes between baseline and post-intervention outcomes across treatment groups. RESULTS Recruitment for this study began in April 2023, and was completed in February of 2024, with a total of 139 participants successfully enrolled. Data collection has concluded, and the first results are expected in the spring of 2026. CONCLUSIONS This study is the first randomized trial to assess the impact of a caregiver proxy-reported, EHR-integrated, pre-clinic questionnaire distributed via a patient portal on caregiver-perceived quality of care in a pediatric care setting. Results will guide changes in health service infrastructure and delivery to enhance comprehensive data capture and improve care quality within and beyond pediatric T1D. CLINICALTRIAL ClinicalTrials.gov NCT05979077; https://clinicaltrials.gov/study/NCT05979077?term=NCT05979077&rank=1
- 13 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCan We Improve Quality of Care in a Diabetes Clinic Through Patient-Entered Electronic Health Data?: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Quality care for pediatric type 1 diabetes (T1D) requires frequent, multidisciplinary visits. Technological and clinical innovation have led to changes in T1D management resulting in increasing data exchange required during these visits. Capturing comprehensive personal health and diabetes-related information discretely and integrating it into the clinical workflow is critical for optimal T1D care, but time consuming. Time spent on data transfer often results in less time for holistic care, and can result in unmet needs for patients, families and health care providers, and increased time pressures in clinic. To address this, the Children’s Hospital of Eastern Ontario (CHEO) developed a caregiver proxy-reported questionnaire distributed via the MyChart® patient portal, allowing families to input care information ahead of visits, with the aim of dedicating more clinic time to personalized care. The launch of this tool that integrates caregiver-entered information directly into the physician’s documentation workflow, brings the opportunity to systematically evaluate its impact on care quality and efficiency, with potential implications for broader adoption. OBJECTIVE Our objective is to evaluate the impact of a caregiver proxy-reported, EHR-integrated pre-clinic questionnaire (MyChart questionnaire) on the quality of care in a pediatrics diabetes clinic, through measurement of its impact on caregiver-perceived quality of care compared to standard of care using two validated measures of care quality. We also aim to explore the impact of the intervention on glycemic control and visit efficiency. METHODS We conducted a single-centre, parallel-group randomized controlled trial designed for 222 children with T1D. Participants were randomly allocated in a 1:1 ratio to either the intervention (MyChart questionnaire) or standard care. Our primary outcome is caregiver-perceived quality of care as measured by the Patient’s Evaluation of the Quality of Diabetes Care (PEQD) at 8 months, administered with caregivers serving as proxy respondents for patients. Secondary outcomes are the PEQD at 4 months and Perceived Quality of Medical Care (PQMC) at 4 and 8 months. Tertiary outcomes include glycemic control and physician-reported visit efficiency at 4 and 8 months. ANCOVA models will be used to assess changes between baseline and post-intervention outcomes across treatment groups. RESULTS Recruitment for this study began in April 2023, and was completed in February of 2024, with a total of 139 participants successfully enrolled. Data collection has concluded, and the first results are expected in the spring of 2026. CONCLUSIONS This study is the first randomized trial to assess the impact of a caregiver proxy-reported, EHR-integrated, pre-clinic questionnaire distributed via a patient portal on caregiver-perceived quality of care in a pediatric care setting. Results will guide changes in health service infrastructure and delivery to enhance comprehensive data capture and improve care quality within and beyond pediatric T1D. CLINICALTRIAL ClinicalTrials.gov NCT05979077; https://clinicaltrials.gov/study/NCT05979077?term=NCT05979077&rank=1
- Open Access
- 5 June 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (s2) , S79
P.076 Tone management: an environmental scan of current management practices across Canada
Background: Currently, there are no standardized approaches to care or evaluation for tone dysfunction in Canada. The study authors hypothesize that there is significant practice variation across the country. This environmental scan is aimed to describe the current practice for management of patients with hypertonia across Canada. Methods: A web-based survey was developed by the authors with a multi-disciplinary approach and sent to representative rehabilitation sites in each province. All statistical analyses were performed using the R statistical software version 4.0. Results: CP was found to be the most common diagnosis for tone dysfunction, with 58% (7/12) of sites diagnosing greater than 20 new patients per year. All 12 sites offered oral baclofen and gabapentin, and 92% of sites offered trihexyphenidyl. Botulinum toxin injections were offered at 50% of sites. Upper and lower extremity procedures were offered in 83% of the sites. In 8 of 12 sites (67%), patients were seen within a formal multidisciplinary clinic to manage hypertonia. Conclusions: The information gained from this study provides some insight into the current practice across Canada for children with hypertonia. This study may assist in the development of a national, standardized strategy to tone management, potentially facilitating more equitable access to care for patients.
- 5 June 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (s2) , S79
Open AccessP.076 Tone management: an environmental scan of current management practices across Canada
Background: Currently, there are no standardized approaches to care or evaluation for tone dysfunction in Canada. The study authors hypothesize that there is significant practice variation across the country. This environmental scan is aimed to describe the current practice for management of patients with hypertonia across Canada. Methods: A web-based survey was developed by the authors with a multi-disciplinary approach and sent to representative rehabilitation sites in each province. All statistical analyses were performed using the R statistical software version 4.0. Results: CP was found to be the most common diagnosis for tone dysfunction, with 58% (7/12) of sites diagnosing greater than 20 new patients per year. All 12 sites offered oral baclofen and gabapentin, and 92% of sites offered trihexyphenidyl. Botulinum toxin injections were offered at 50% of sites. Upper and lower extremity procedures were offered in 83% of the sites. In 8 of 12 sites (67%), patients were seen within a formal multidisciplinary clinic to manage hypertonia. Conclusions: The information gained from this study provides some insight into the current practice across Canada for children with hypertonia. This study may assist in the development of a national, standardized strategy to tone management, potentially facilitating more equitable access to care for patients.
- Open Access
- 3 June 2023
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 36 (4) , 217-223
A climate resilience maturity matrix for Canadian health systems
Healthcare decision-makers are becoming increasingly aware that climate change poses significant threats to population health and continued delivery of quality care. Challengingly, responding to climate change requires complex, often expensive, and multi-faceted actions to limit new emissions from worsening climate trajectories, while investing in climate-resilient systems. We present a Climate Resilience Maturity Matrix that brings together both mitigation and adaptation actions into a high-level tool for health leaders, for supporting organizational review, assessment, and decision-making for climate change readiness. This tool is designed to (i) support leaders in Canadian health facilities and regional health authorities in designing mitigation and adaptation roadmaps, (ii) support decision-making for climate change-related strategic planning processes, and (iii) create a high-level overview of organizational readiness. This tool is intended to consolidate key data, provide a clear communication tool, allow for objective rapid baselining, enable system-level gap analysis, facilitate comparability/transparency, and support rapid learning cycles.
- 3 June 2023
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 36 (4) , 217-223
Open AccessA climate resilience maturity matrix for Canadian health systems
Healthcare decision-makers are becoming increasingly aware that climate change poses significant threats to population health and continued delivery of quality care. Challengingly, responding to climate change requires complex, often expensive, and multi-faceted actions to limit new emissions from worsening climate trajectories, while investing in climate-resilient systems. We present a Climate Resilience Maturity Matrix that brings together both mitigation and adaptation actions into a high-level tool for health leaders, for supporting organizational review, assessment, and decision-making for climate change readiness. This tool is designed to (i) support leaders in Canadian health facilities and regional health authorities in designing mitigation and adaptation roadmaps, (ii) support decision-making for climate change-related strategic planning processes, and (iii) create a high-level overview of organizational readiness. This tool is intended to consolidate key data, provide a clear communication tool, allow for objective rapid baselining, enable system-level gap analysis, facilitate comparability/transparency, and support rapid learning cycles.
- 19 May 2023
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 36 (4) , 195-198
Climate action, staff engagement, and change management: A paediatric hospital case study
Planetary health and triple bottom line accounting are concepts healthcare organizations are starting to grapple with. While a few Canadian hospitals are early pioneers in efforts to deliver healthcare with less greenhouse gases, many hospitals struggle with adding a climate lens to their operations. This case study highlights a five year journey at CHEO to roll-out a hospital-wide climate strategy. CHEO has created new reporting structures, revised resource allocation, and launched net-zero targets. This hospital net-zero case study is an illustration of climate actions, given certain contexts, rather than a roadmap. Establishing this hospital-wide strategic pillar—during a global pandemic—has yielded (i) cost savings, (ii) an inspired workforce, and (iii) meaningful greenhouse gas reductions.
- 19 May 2023
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 36 (4) , 195-198
Climate action, staff engagement, and change management: A paediatric hospital case study
Planetary health and triple bottom line accounting are concepts healthcare organizations are starting to grapple with. While a few Canadian hospitals are early pioneers in efforts to deliver healthcare with less greenhouse gases, many hospitals struggle with adding a climate lens to their operations. This case study highlights a five year journey at CHEO to roll-out a hospital-wide climate strategy. CHEO has created new reporting structures, revised resource allocation, and launched net-zero targets. This hospital net-zero case study is an illustration of climate actions, given certain contexts, rather than a roadmap. Establishing this hospital-wide strategic pillar—during a global pandemic—has yielded (i) cost savings, (ii) an inspired workforce, and (iii) meaningful greenhouse gas reductions.
- Open Access
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 120
SP02. Outcomes after First Myringotomy Tube Insertion in Children with Cleft Pathology Treated at an Approved ACPA Centre
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 120
Open AccessSP02. Outcomes after First Myringotomy Tube Insertion in Children with Cleft Pathology Treated at an Approved ACPA Centre
- 17 March 2023
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 45 (5) , 329-330
Antibiotic Eye Prophylaxis for Newborns: Using the Topical Erythromycin Shortage as an Opportunity to Reflect on Practice Evolution
- 17 March 2023
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 45 (5) , 329-330
Antibiotic Eye Prophylaxis for Newborns: Using the Topical Erythromycin Shortage as an Opportunity to Reflect on Practice Evolution
- Open Access
- 30 March 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (3) , ED000156
Protecting human health in a time of climate change: how Cochrane should respond
- 30 March 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (3) , ED000156
Open AccessProtecting human health in a time of climate change: how Cochrane should respond
Referral practices for epilepsy surgery in pediatric patients: A North American Study
Objective: Patients with epilepsy who do not respond to two trials of appropriate antiepileptic drugs are considered to have drug‐resistant epilepsy (DRE). The International League Against Epilepsy recommends patients with DRE be referred for surgical evaluation; however, prior literature suggests this is an underutilized intervention, especially in the pediatric setting. This study captures practices of North American pediatric neurologists regarding the management of DRE and factors that may promote or limit referrals for epilepsy surgical evaluation.Methods: A REDCap survey was distributed via the Child Neurology Society mailing list to pediatric neurologists practicing in North America. Ethics approval from the Children's Hospital of Eastern Ontario Research Ethics Board was granted prior to the start of data collection.Results: Ninety‐eight responses were included in the analysis; 77% of participants currently practice in the United States; 73.5% of respondents reported they would refer a patient for surgical consultation after two failed medications. Of all potential predictors tested in a binary logistic regression model, only annual referral volume predicted whether participants refer patients after three or more failed medications. Centers with high referral volume were 37% more likely to adhere to the guideline of referral after two failed medications.Significance: Pediatric neurologists demonstrate fair knowledge of formal recommendations to refer patients for surgical evaluation after two failed medication trials, although referral rates remain unacceptably low. Participants continue to report that they would not refer patients with generalized electroencephalographic findings for surgical evaluation; this should continue to be addressed. Other modifiable factors reported, especially family perceptions of epilepsy surgery, should be prioritized when developing tools to enhance effective referrals and increase utilization of epilepsy surgery in the management of pediatric DRE.
Referral practices for epilepsy surgery in pediatric patients: A North American Study
Objective: Patients with epilepsy who do not respond to two trials of appropriate antiepileptic drugs are considered to have drug‐resistant epilepsy (DRE). The International League Against Epilepsy recommends patients with DRE be referred for surgical evaluation; however, prior literature suggests this is an underutilized intervention, especially in the pediatric setting. This study captures practices of North American pediatric neurologists regarding the management of DRE and factors that may promote or limit referrals for epilepsy surgical evaluation.Methods: A REDCap survey was distributed via the Child Neurology Society mailing list to pediatric neurologists practicing in North America. Ethics approval from the Children's Hospital of Eastern Ontario Research Ethics Board was granted prior to the start of data collection.Results: Ninety‐eight responses were included in the analysis; 77% of participants currently practice in the United States; 73.5% of respondents reported they would refer a patient for surgical consultation after two failed medications. Of all potential predictors tested in a binary logistic regression model, only annual referral volume predicted whether participants refer patients after three or more failed medications. Centers with high referral volume were 37% more likely to adhere to the guideline of referral after two failed medications.Significance: Pediatric neurologists demonstrate fair knowledge of formal recommendations to refer patients for surgical evaluation after two failed medication trials, although referral rates remain unacceptably low. Participants continue to report that they would not refer patients with generalized electroencephalographic findings for surgical evaluation; this should continue to be addressed. Other modifiable factors reported, especially family perceptions of epilepsy surgery, should be prioritized when developing tools to enhance effective referrals and increase utilization of epilepsy surgery in the management of pediatric DRE.
- 1 February 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 115, 107722
Poor adherence to sleep and physical activity guidelines among children with epilepsy
- 1 February 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 115, 107722
Poor adherence to sleep and physical activity guidelines among children with epilepsy